2018 Annual Sessions

OS22 - ORAL SESSION 22 - Trials and Treatments in Lung Transplantation

Apr 12, 2018 6:00pm ‐ Apr 12, 2018 6:00pm


Description

(200)  A Prospective, Randomized, Placebo-controlled Trial of Pre-transplant and Prompt Post-transplant Treatment With Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation (NCT01915082)
Anke Van Herck, MD

(201)  A Randomized Controlled Trial of Naloxone for Optimization of Hypoxemia in Lung Donors
Rajat Dhar, MD

(202)  Improved Lung Preservation in the Organ Care System in a Porcine Transplantation Setting Modelled After the INSPIRE Trial Triggers a Proregulatory T Cell Phenotype
Jawad Salman, Dr

(203)  Human Leukocyte Antigen Allosensitization in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation
Maria Molina, MSN, CRNP

(204)  Influence of an IgM-enriched Intravenous Immunoglobulin-based Treatment on Regulatory T Cells in Patients with Donor Specific Antibodies After Lung Transplantation
Fabi Ius, MD

(205)  Anastomotic Outcomes in Idiopathic Pulmonary Fibrosis Patients Receiving Anti-Fibrotic Therapy: Experience of the Australian Lung Transplant Collaborative
John Mackintosh

Speaker(s):

Tags: LTX PHARM

You must be logged in and own this session in order to post comments.